In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Gene Therapy

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3301284PMID 11083475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Localization and effects of hepatocyte growth factor on smooth muscle cells during neointimal formation after balloon denudation

  1999cited by this paper
• Negative Regulation of Local Hepatocyte Growth Factor Expression by Angiotensin II and Transforming Growth Factor-β in Blood Vessels Protential Role of HGF in Cardiovascular Disease

  1999cited by this paper
• Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury.

  1999cited by this paper
• A Vascular Modulator, Hepatocyte Growth Factor, Is Associated With Systolic Pressure

  1999cited by this paper
• Adenovirus-Mediated Gene Transfer of the Human TIMP-1 Gene Inhibits Smooth Muscle Cell Migration and Neointimal Formation in Human Saphenous Vein

  1998cited by this paper
• Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease.

  1998cited by this paper
• Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease.

  1998cited by this paper
• Hemagglutinating virus of Japan-liposome-mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff.

  1998cited by this paper
• Potential Role of an Endothelium-Specific Growth Factor, Hepatocyte Growth Factor, on Endothelial Damage in Diabetes

  1997cited by this paper
• Molecular analysis of blood vessel formation and disease.

  1997cited by this paper
• Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor

  1997cited by this paper
• Molecular analysis of blood vessel formation and disease.

  1997cited by this paper
• In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

  1997cited by this paper
• Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration.

  1997cited by this paper
• Emerging multipotent aspects of hepatocyte growth factor.

  1996cited by this paper
• Arterial gene therapy for restenosis.

  1996cited by this paper
• Arterial Gene Therapy for Restenosis. St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts

  1996cited by this paper
• Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer.

  1996cited by this paper
• A vascular modulator, hepatocyte growth factor, is associated with systolic pressure.

  1996cited by this paper
• Arterial gene therapy

  1996cited by this paper
• Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (hemagglutinating virus of Japan) liposomes: an effective tool for the in vivo study of arterial diseases.

  1996cited by this paper
• Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor

  1996cited by this paper
• Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells.

  1996cited by this paper
• Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

  1995cited by this paper
• Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery.

  1995cited by this paper
• Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

  1995cited by this paper
• Expression of local hepatocyte growth factor system in vascular tissues.

  1995cited by this paper
• A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

  1995cited by this paper
• Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.

  1995cited by this paper
• Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues

  1995cited by this paper
• Gene therapy inhibiting neointimal vascular lesion

  1995cited by this paper
• Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.

  1994cited by this paper
• A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family.

  1994cited by this paper
• Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction

  1994cited by this paper
• The emerging concept of vascular remodeling.

  1994cited by this paper
• Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation.

  1994cited by this paper
• Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells.

  1993cited by this paper
• The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes.

  1993cited by this paper
• Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

  1993cited by this paper
• A Cascade Model for Restenosis: A Special Case of Atherosclerosis Progression

  1992cited by this paper
• Migration of Smooth Muscle and Endothelial Cells: Critical Events in Restenosis

  1992cited by this paper
• Endothelium and Growth Factors in Vascular Remodeling of Hypertension

  1991cited by this paper
• Organization of the human hepatocyte growth factor-encoding gene.

  1991cited by this paper
• Regulation of Smooth Muscle Cell Growth in Injured Artery

  1989cited by this paper
• Increased expression of DNA cointroduced with nuclear protein in adult rat liver.

  1989cited by this paper
• Molecular cloning and expression of human hepatocyte growth factor

  1989cited by this paper
• Prejunctional and postjunctional actions of prostaglandins F2 alpha and I2 and carbocyclic thromboxane A2 in isolated dog mesenteric arteries.

  1986cited by this paper

• Development of heparinized and hepatocyte growth factor-coated acellular scaffolds using porcine carotid arteries.

  2023cites this paper
• Surface Engineering of Cardiovascular Devices for Improved Hemocompatibility and Rapid Endothelialization

  2020cites this paper
• Eva1a ameliorates atherosclerosis by promoting re-endothelialization of injured arteries via Rac1/Cdc42/Arpc1b.

  2020cites this paper
• The Development of a Dual-ligand PEGylated Liposome Nanotechnology for Cell-selective Targeted Vascular Gene Therapy

  2019cites this paper
• Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model

  2018cites this paper
• Overexpression of Hepatocyte Growth Factor mRNA Induced by Gene Transfer Attenuates Neointimal Hyperplasia After Balloon Injury

  2018cites this paper
• Randomized Comparison of Strut Coverage between Ticagrelor and Clopidogrel in Acute Myocardial Infarction at 3-Month Optical Coherence Tomography

  2018cites this paper
• Serum Hepatocyte Growth Factor Is Probably Associated With 3-Month Prognosis of Acute Ischemic Stroke

  2018cites this paper
• Angiogenesis-Based Strategy by Hepatocyte Growth Factor for the Treatment of Ischemic Organ Diseases: From Biology to Clinical Trials

  2017cites this paper
• Human hepatocyte growth factor inhibits early neointima formation in rabbit abdominal aortae following ultrasound-guided balloon injury

  2017influential citation
• Improving the efficacy of liposome-mediated vascular gene therapy via lipid surface modifications.

  2017cites this paper
• A Cytokine-Like Protein Dickkopf-Related Protein 3 Is Atheroprotective

  2017cites this paper
• A Cytokine-like Protein DKK 3 Is Atheroprotective Running Title :

  2017cites this paper
• Substrate Stiffness Combined with Hepatocyte Growth Factor Modulates Endothelial Cell Behavior.

  2016cites this paper
• Transforming Growth Factor-β(beta) Targeting Strategies for Prevention of Coronary Arterial Restenosis Post-angioplasty

  2016cites this paper
• Inducible HGF-secreting Human Umbilical Cord Blood-derived MSCs Produced via TALEN-mediated Genome Editing Promoted Angiogenesis

  2016cites this paper
• Alpha-1 proteinase inhibitor M358R reduces thrombin generation when displayed on the surface of cells expressing tissue factor.

  2014cites this paper
• Molecular Determinants of Cardiac Neovascularization

  2014cites this paper
• Hepatocyte Growth Factor: Cardiotrophic Roles and Potential Therapeutics for Cardiovascular Diseases

  2014influential citation
• The dipeptidyl peptidase-4 inhibitor teneligliptin improved endothelial dysfunction and insulin resistance in the SHR/NDmcr-cp rat model of metabolic syndrome

  2014cites this paper
• Surface-mediated functional gene delivery: an effective strategy for enhancing competitiveness of endothelial cells over smooth muscle cells.

  2013cites this paper
• Long-term clinical performance of paclitaxel-eluting stents coated with a bioactive polymer (P-5) containing a triflusal derivative: results of the REWAC registry.

  2013cites this paper
• Physiological Roles and Therapeutic Implications of Hepatocyte Growth Factor for Angiogenesis

  2013cites this paper
• Gene Therapy for Restenosis

  2012cites this paper
• Hemodialysis Vascular Access Dysfunction: Molecular Mechanisms and Treatment

  2012cites this paper
• Effects of insulin on the vasculature.

  2011cites this paper
• Ezetimibe and reactive oxygen species.

  2011cites this paper
• Silencing of int 6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease

  2011cites this paper
• Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease.

  2011cites this paper
• Obesity and gastrointestinal hormones-dual effect of angiotensin II receptor blockade and a partial agonist of PPAR-γ.

  2011cites this paper
• In vivo evaluation of a novel dexamethasone-heparin-double-coated stent for inhibition of artery restenosis and thrombosis

  2011cites this paper
• Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.

  2011cites this paper
• Modulation of cell adhesion, proliferation and differentiation on materials designed for body implants.

  2011cites this paper
• A tandem repeat of a fragment of Listeria monocytogenes internalin B protein induces cell survival and proliferation.

  2010cites this paper
• Over-expression of hepatocyte growth factor in smooth muscle cells regulates endothelial progenitor cells differentiation, migration and proliferation.

  2010cites this paper
• Hepatocyte growth factor is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients

  2010cites this paper
• Insulin Increases Reendothelialization and Inhibits Cell Migration and Neointimal Growth After Arterial Injury

  2009cites this paper
• Lipids in Health and Disease

  2009cites this paper
• Vascular protective effects of ezetimibe in ApoE-deficient mice.

  2009cites this paper
• The role of progenitor cells in the development of intimal hyperplasia.

  2009cites this paper
• Hepatocyte growth factor levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in patients with type 2 diabetes mellitus.

  2009cites this paper
• Transfection of HGF gene enhances endothelial progenitor cell (EPC) function and improves EPC transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats.

  2009cites this paper
• Differential response of vascular hepatocyte growth factor concentration and lipid accumulation between telmisartan and losartan in ApoE-deficient mice.

  2008cites this paper
• Intracellular Ca2+ stores are essential for injury induced Ca2+ signaling and re‐endothelialization

  2008cites this paper
• Hyperplasie intimale artérielle par prolifération de cellules musculaires lisses dans la paroi

  2008cites this paper
• Lipids in Health and Disease

  2008cites this paper
• Statins and the endothelium.

  2007cites this paper
• Predictors for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis.

  2007cites this paper
• Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction

  2007cites this paper
• Angiogenic growth factors in the treatment of peripheral arterial disease.

  2007cites this paper
• Improvement of organ damage by a non-depressor dose of imidapril in diabetic spontaneously hypertensive rats.

  2007cites this paper
• The importance of reendothelialization after arterial injury.

  2007cites this paper
• Hepatocyte growth factor fusion protein having collagen-binding activity (CBD-HGF) accelerates re-endothelialization and intimal hyperplasia in balloon-injured rat carotid artery.

  2007cites this paper
• Hepatocyte growth factor/scatter factor and MET are involved in arterial repair and atherogenesis.

  2006cites this paper
• Transfection of Human Hepatocyte Growth Factor Gene Ameliorates Secondary Lymphedema via Promotion of Lymphangiogenesis

  2006cites this paper
• Gene Therapy vs Pharmacotherapy

  2005cites this paper
• Vascular access in hemodialysis: issues, management, and emerging concepts.

  2005cites this paper
• Angiogenic Factors in Human Atherosclerotic Lesions and Relationship to Intraplaque Angiogenesis

  2005cites this paper
• A scientific rationale for the CREST trial results: evidence for the mechanism of action of cilostazol in restenosis.

  2005cites this paper
• A calcium‐channel blocker, benidipine, improves forearm reactive hyperemia in patients with essential hypertension

  2005cites this paper
• A new signaling mechanism of hepatocyte growth factor‐induced endothelial proliferation

  2005cites this paper
• Oxidized LDL inhibit hepatocyte growth factor synthesis in coronary smooth muscle cells.

  2005cites this paper
• Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal

  2005cites this paper
• Suppression of Acute and Chronic Rejection by Hepatocyte Growth Factor in a Murine Model of Cardiac Transplantation: Induction of Tolerance and Prevention of Cardiac Allograft Vasculopathy

  2004cites this paper
• Vascular Endothelial Growth Factor Regulates Reendothelialization and Neointima Formation in a Mouse Model of Arterial Injury

  2004cites this paper
• Gene therapy for restenosis--what now, what next?

  2004cites this paper
• Perspective in progress of cardiovascular gene therapy.

  2004cites this paper
• Combined administration of basic fibroblast growth factor protein and the hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds

  2004cites this paper
• Gene therapy for cardiovascular diseases.

  2004cites this paper
• Exercise-induced hepatocyte growth factor production in patients after acute myocardial infarction: its relationship to exercise capacity and brain natriuretic peptide levels.

  2004cites this paper
• Hepatocyte growth factor stimulates nitric oxide production through endothelial nitric oxide synthase activation by the phosphoinositide 3-kinase/Akt pathway and possibly by mitogen-activated protein kinase kinase in vascular endothelial cells.

  2004cites this paper
• Effect of nifedipine on endothelial function in normotensive smokers: potential contribution of increase in circulating hepatocyte growth factor

  2004cites this paper
• Therapeutic angiogenesis using hepatocyte growth factor (HGF).

  2004cites this paper
• Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor.

  2004cites this paper
• Gene therapy approaches for the prevention of restenosis.

  2004cites this paper
• Novel Therapies for Hemodialysis Vascular Access Dysfunction: Fact or Fiction!

  2004cites this paper
• Hemodialysis Vascular Access Dysfunction: From Pathophysiology to Novel Therapies

  2003cites this paper
• Delivery of a growth factor fusion protein having collagen-binding activity to wound tissues.

  2003cites this paper
• The Emerging Role of Gene Therapy in the Treatment of Cardiovascular Diseases

  2003cites this paper
• The N-terminal Domain of Hepatocyte Growth Factor Inhibits the Angiogenic Behavior of Endothelial Cells Independently from Binding to the c-met Receptor*

  2003cites this paper
• Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats

  2003cites this paper
• [Hyperplasia of the arterial intima due to smooth muscle cell proliferation. Current data, experimental treatments and perspectives].

  2003cites this paper
• Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular disease.

  2002cites this paper
• Hyperthermia at 43 degrees C for 2h inhibits the proliferation of vascular smooth muscle cells, but not endothelial cells.

  2002cites this paper
• Plasma hepatocyte growth factor and the relationship between risk factors and carotid atherosclerosis.

  2002cites this paper
• Impaired endothelial dysfunction in diabetes mellitus rats was restored by oral administration of prostaglandin I2 analogue.

  2002cites this paper
• Molecular strategy using cis-element ‘decoy’ of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model

  2002cites this paper
• Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques.

  2002cites this paper
• Hyperthermia at 43°C for 2h Inhibits the Proliferation of Vascular Smooth Muscle Cells, but not Endothelial Cells

  2002cites this paper
• Platelet-derived CD40L: the switch-hitting player of cardiovascular disease.

  2002cites this paper
• Recent progress in gene therapy for cardiovascular disease.

  2002cites this paper
• Post-intervention vessel remodeling

  2002cites this paper
• Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model

  2001cites this paper
• Association between carotid arterial remodeling and plasma concentration of circulating hepatocyte growth factor

  2001cites this paper
• Inhibition of Neointima by Angiotensin-Converting Enzyme Inhibitor in Porcine Coronary Artery Balloon-Injury Model

  2001cites this paper